Align Technology (ALGN) Stock Overview
Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ALGN Community Fair Values
Create NarrativeSee what 58 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
US$154.62
FV
11.9% overvalued intrinsic discount4.80%
Revenue growth p.a.
190
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Align Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$172.96 |
| 52 Week High | US$200.44 |
| 52 Week Low | US$122.00 |
| Beta | 1.65 |
| 1 Month Change | -3.62% |
| 3 Month Change | 6.93% |
| 1 Year Change | 23.11% |
| 3 Year Change | -52.10% |
| 5 Year Change | -74.60% |
| Change since IPO | 899.02% |
Recent News & Updates
Seeking Alpha • Aug 07
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking Alpha
Narrative Update • Jul 30
ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution
Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.Recent updates
Seeking Alpha • Aug 07
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Summary Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow. Key risks include EU antitrust investigation, North American demand softness, iTero revenue declines, and potential activist-driven structural changes. Read the full article on Seeking AlphaNarrative Update • Jul 30
ALGN: Future Returns Will Depend On Execution And EU Antitrust Resolution
Align Technology's updated analyst model trims the fair value estimate by $5 to $170 as analysts factor in a slightly lower assumed revenue growth profile, a modestly higher margin outlook, and a reduced future P/E multiple, despite recent price target support from firms citing potential long term drivers and limited fundamental impact from the EU antitrust case. Analyst Commentary on Align Technology Street research on Align Technology presents a mixed picture, with some analysts highlighting long term growth drivers while others focus on valuation risks and legal overhangs.
Narrative Update • Jul 01
ALGN: Platform Execution And Limited EU Antitrust Impact Will Drive Repricing
Align Technology's updated analyst price target moves higher to $209.07, with analysts pointing to detailed platform growth levers and limited expected fundamental impact from the EU antitrust case as key supports for the revised fair value and P/E assumptions. Analyst Commentary Analysts covering Align Technology describe a mix of supportive long-term growth drivers and near term headline risks, with recent price targets and commentary reflecting how they weigh platform execution against regulatory uncertainty.
Narrative Update • Jun 17
ALGN: Multi-Year Upside Will Rely On Platform Expansion And Direct Fabrication
Align Technology's latest narrative update keeps the fair value unchanged at $240.00. Analysts point to a slightly lower discount rate, modestly adjusted revenue growth and profit margin assumptions, and Street research highlighting teen conversion, restorative treatment partnerships, software improvements, and direct fabrication scaling as reasons for a higher collective price target outlook.Narrative Update • Jun 02
ALGN: Future Returns Will Rely On Execution And Elliott Engagement
Analysts have nudged their price expectations for Align Technology higher, setting a new target of $175.00. This view is supported by the belief that multiple growth levers across teen conversion, restorative treatments, peer-to-peer expansion, software evolution, and manufacturing scale may not yet be fully reflected in the current stock price.Analysis Article • May 18
We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit
Align Technology, Inc.'s ( NASDAQ:ALGN ) recent earnings report didn't offer any surprises, with the shares unchanged...Narrative Update • May 12
ALGN: Higher Future Multiple Will Depend On Execution And Elliott Engagement
Narrative Update on Align Technology The updated analyst price target for Align Technology moves to $175.00 from $152.60, with analysts citing a higher assumed future P/E multiple, along with slightly lower modeled revenue growth and profit margins, as key reasons for the change. Analyst Commentary Recent research on Align Technology reflects a mix of optimism and caution, with several firms adjusting price targets and ratings over the past few months.Narrative Update • Apr 21
ALGN: Higher Fair Value Will Follow Renewed Bullish Rating And Governance Catalyst
The analyst fair value estimate for Align Technology moves to $240 from $225, with analysts pointing to recent Street research that reflects updated views on revenue growth, margins, and P/E assumptions following multiple price target raises and positive rating actions. Analyst Commentary Recent Street research on Align Technology has leaned more constructive, with several bullish analysts updating their views on the company and its valuation framework.Narrative Update • Apr 07
ALGN: Post Conflict Recovery And Elliott Involvement Will Drive Bullish Repricing
The analyst price target for Align Technology holds at $200, as analysts point to an improved risk/reward skew after the recent pullback and highlight the company as well positioned once regional conflict pressures ease. Analyst Commentary Bullish analysts see the recent pullback as improving the setup for Align Technology, with the stock trading below its February levels after a 15% decline linked to Middle East conflict headlines.Narrative Update • Mar 23
ALGN: Post Conflict Demand Recovery And Elliott Engagement Will Shape Bullish Risk Reward
Align Technology's analyst fair value estimate has shifted modestly higher to about $201.69 from $198.67, as analysts point to an improved risk and reward setup following recent share weakness and a series of price target increases. These include a reiterated $200 target alongside an upgrade to Overweight at Barclays, as well as similar upward moves from several other firms.Narrative Update • Mar 08
ALGN: Higher Fair Value Will Reflect Stronger Revenue And Margin Assumptions
The analyst fair value estimate for Align Technology has moved to $225 from $220, with the shift supported by recent price target increases across multiple firms and updated assumptions for revenue growth, profit margin, and a lower future P/E, partially offset by a higher discount rate. Analyst Commentary Recent Street research has centered on higher price targets and at least one fresh upgrade, which together align with the updated fair value estimate of US$225.Narrative Update • Feb 22
ALGN: Margin Execution And P/E Expectations Will Shape Fairly Balanced Outlook
Align Technology's analyst price target has moved higher, with fair value estimates shifting from about $184 to roughly $199. Analysts are factoring in slightly stronger margin assumptions and a higher future P/E multiple, supported by a series of recent price target increases across major firms.Narrative Update • Feb 08
ALGN: Future Multiple Compression Risk Will Test Execution Dependent Story
Analysts have lifted their price expectations for Align Technology, reflected in a higher implied fair value from about $140.00 to roughly $152.60, citing updated assumptions around revenue growth, profitability and future P/E multiples in recent research. Analyst Commentary Recent research activity around Align Technology has centered on revisiting fair value frameworks, with several firms adjusting price targets based on updated views of revenue potential, profitability and appropriate P/E multiples.Narrative Update • Jan 25
ALGN: Q3 Volume Strength And Visibility Concerns Will Shape Balanced Outlook
Analysts have nudged their fair value estimate for Align Technology up by about $3 to $183.87, citing recent price target increases that reflect improved confidence in the company’s volume trends and revenue visibility following Q3 results. Analyst Commentary Recent research on Align Technology highlights a mix of optimism on execution following Q3 and ongoing caution around demand visibility and expectations for upcoming quarters.Narrative Update • Jan 10
ALGN: Q3 Volume Strength And Cautious Outlook Will Shape Fairly Balanced Expectations
Narrative Update The analyst price target for Align Technology is now framed by a modestly higher intrinsic value estimate of about $180.47 per share, as analysts weigh recent target revisions around $200 and $170 against updated assumptions for growth, margins and future P/E. Analyst Commentary Recent Street commentary on Align Technology reflects a mix of renewed confidence in execution and ongoing caution around revenue visibility and the path to growth.Analysis Article • Jan 04
Returns On Capital Are Showing Encouraging Signs At Align Technology (NASDAQ:ALGN)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Narrative Update • Dec 21
ALGN: Q3 Volume Gains Will Support Renewed Confidence In Upcoming Revenue Ramp
Analysts have modestly raised their price target on Align Technology to $200 from $190, reflecting improved confidence in management's restored revenue visibility and Q4 execution following broad-based Q3 volume upside, even as valuation assumptions and long term growth forecasts remain largely unchanged. Analyst Commentary Recent Street commentary on Align Technology reflects a more constructive stance on near term execution, balanced by lingering questions around the durability of growth and visibility into 2025.Narrative Update • Dec 07
ALGN: Q3 Volume Strength Will Support Confidence In Upcoming Revenue Ramp
Analysts have nudged their average price target on Align Technology modestly higher, by roughly $4 to about $184, as stronger than expected Q3 volume trends and improved visibility into hitting year end revenue goals outweighed lingering concerns about the pace of sequential improvement. Analyst Commentary Recent research updates reflect a generally constructive stance on Align Technology, with some lingering caution around execution into Q4 and beyond.Narrative Update • Nov 23
ALGN: Recent Revenue Upside Will Improve Confidence In Forward Momentum
Analysts have raised their price target for Align Technology from $190 to $200 per share, citing improved revenue visibility and a stronger than expected third-quarter performance. Analyst Commentary Analysts have weighed in with both optimism and caution regarding Align Technology's outlook, highlighted by recent changes in price targets and ratings.Narrative Update • Nov 08
ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook
Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.Narrative Update • Oct 24
Digital Workflow Improvements And Market Weakness Will Shape The Coming Year
Analysts have lowered their price target for Align Technology by approximately $5 to $175. They cite slightly softer revenue growth projections, modestly reduced profit margin expectations, and increased uncertainty around guidance for the upcoming quarters.Narrative Update • Oct 10
Emerging Markets And Digital Workflow Will Fuel Future Success
Analysts have modestly lowered their price target for Align Technology, trimming it by approximately $6 to $180. Updated industry surveys and company results reflect both ongoing optimism and continued challenges in the dental market.Seeking Alpha • Mar 07
Align Technology: Brace Yourself, This Stock Is Undervalued
Summary Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation. ALGN's market potential is strong, particularly with younger demographics, although recent revenue per shipment has softened. Read the full article on Seeking AlphaSeeking Alpha • Jan 05
Align Technology: Economic Headwinds Cloud An Attractive Growth Story
Summary Align Technology shares have remained under pressure over the past year due to soft consumer demand for the company’s clear aligner products. I expect growth to accelerate to at least 5% in FY25, mainly driven by strong demand for the systems and services that are sold to doctors. Profit margins are expected to improve, following the restructuring program initiated in Q4. Despite certain key risks, I find the valuation at 20.4 times FCF compelling enough to justify a Buy rating for this dominant player in the industry. Read the full article on Seeking AlphaShareholder Returns
| ALGN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.2% | 2.7% | 0.09% |
| 1Y | 23.1% | -10.6% | 19.0% |
Return vs Industry: ALGN exceeded the US Medical Equipment industry which returned -11.1% over the past year.
Return vs Market: ALGN exceeded the US Market which returned 20.9% over the past year.
Price Volatility
| ALGN volatility | |
|---|---|
| ALGN Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ALGN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ALGN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 20,435 | Joe Hogan | www.aligntech.com |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions.
Align Technology, Inc. Fundamentals Summary
| ALGN fundamental statistics | |
|---|---|
| Market cap | US$12.51b |
| Earnings (TTM) | US$413.58m |
| Revenue (TTM) | US$4.14b |
29.7x
P/E Ratio3.0x
P/S RatioIs ALGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALGN income statement (TTM) | |
|---|---|
| Revenue | US$4.14b |
| Cost of Revenue | US$1.23b |
| Gross Profit | US$2.91b |
| Other Expenses | US$2.50b |
| Earnings | US$413.58m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Oct 28, 2026
| Earnings per share (EPS) | 5.82 |
| Gross Margin | 70.36% |
| Net Profit Margin | 9.99% |
| Debt/Equity Ratio | 0% |
How did ALGN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/11 04:18 |
| End of Day Share Price | 2026/08/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Align Technology, Inc. is covered by 42 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Glen Santangelo | Barclays |
| Charley Jones | Barrington Research Associates, Inc. |